Depletion of AADC activity in caudate nucleus and putamen of Parkinson’s disease patients; implications for ongoing AAV2-AADC gene therapy trial

In Parkinson’s disease (PD), aromatic L-amino acid decarboxylase (AADC) is the rate-limiting enzyme in the conversion of L-DOPA (Sinemet) to dopamine (DA). Previous studies in PD animal models demonstrated that lesion of dopaminergic neurons is associated with profound loss of AADC activity in the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciesielska, Agnieszka, Samaranch, Lluis, San Sebastian, Waldy, Dickson, Dennis W., Goldman, Samuel, Forsayeth, John, Bankiewicz, Krystof S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293261/
https://www.ncbi.nlm.nih.gov/pubmed/28166239
http://dx.doi.org/10.1371/journal.pone.0169965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293261/
https://www.ncbi.nlm.nih.gov/pubmed/28166239
http://dx.doi.org/10.1371/journal.pone.0169965

Ejemplares similares